Companion Diagnostics Market – Growth , Opportunities and Applications
Companion Diagnostics is utilized to ascertain who would benefit from treatment and it comes in handy to identify if someone cannot be cured, but also conversely can be harmed by use of specific drug used for their ailment. Technological advancements has brought a lot of changes in the method of disease treatment. Companion diagnostics is characterized by growing requirement for enhancedpersonalized patient treatment that gives healthcare providers and their patients an assurance about the treatment result in a positive way, contrary to traditional treatment procedure. Major impact of companion diagnostic will been on oncology therapy area.
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1255
Companion Diagnostics Market: Drivers and Restraints
Presently, companion diagnostics global market is driven by the technological advancement in healthcare industry, increase in various treatment procedures. Number of companion diagnostics can be given approval for a single drug as scientific knowledge advances with practical application of treatment. Although, cost related with latest technology acts as a key barrier for the growth of global companion diagnostics market.
Companion Diagnostics Market: Segmentation
Companion diagnostic global market is segmented into following segments:
Real Time PCR
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Middle East and Africa (GCC, S. Africa, N. Africa)
Companion Diagnostics Market: Overview
With rapid technological advancement, increase in the incidence of chronic disease, rise in aging population, increasing adoption rate of treatment of chronic disease, increase in number of prevalence of chronic disease around the globe are the factors expected to boost the companion diagnostics market over the forecast period.
Companion Diagnostics Market: Region-wise Outlook
Depending on geographic regions, global companion diagnostics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa.
North America is the leading market for companion diagnostics because of rapid technical inventions, huge investment on research and development in this region. Whereas, Asia-Pacificand Europeis projected to grow at a significant growth due to large consumer base, rising government initiatives for enhancing healthcare infrastructure, and high disposable income.
To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/toc/rep-gb-1255
Companion Diagnostics Market: Key Players
Some of the key participating global players in companion diagnostics market global market are ARUP Laboratories, Roche Molecular Systems Inc., Dako Inc., Qiagen Ltd., bioMérieux Inc.,Ventana Medical Systems Inc., Abbott Molecular Inc., Myriad Genetics Inc.,Biogenex Laboratories, Inc., Thermo Fisher Scientific Inc., Leica Biosystems Nussloch GmbH and others.
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics Market – Growth , Opportunities and Applications here
News-ID: 1501002 • Views: 277
More Releases from Future Market Insights
Ferrovanadium Market to Witness Robust Expansion throughout the Forecast 2018-20 …
Future Market Insights (FMI) analyses the global ferrovanadium market in its new publication titled “Ferrovanadium Market: Global Industry Analysis (2013 – 2017) & Opportunity Assessment (2018 – 2028)”. This study provides data for 2017 along with the forecast for the period (2018–2028). The main objective of the report is to identify the dynamics of the market and provide recent updates and insights pertaining to various segments of the global ferrovanadium
Automotive Lighting Market is expected to grow at a CAGR of ~6% during the forec …
In a recent publication, Future Market Insights (FMI) provides a perspective on the growth trajectory of automotive lighting market for the period between 2019 and 2029. According to the study, worldwide sales of automotive lighting reached ~2 billion units, equating a value of ~US$ 36.5 billion in 2018. Gains remain driven by growing popularity of luxury cars and high purchasing power of middle class demographic in developing countries that increased the
Motorcycle Suspension System Market Size, Share, Industry Analysis, Future Growt …
Future Market Insights has released a new market study on "Motorcycle Suspension System Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028", which studies the global Motorcycle Suspension System market and offers deep dive analysis for the next ten years. The report evaluates all the key macro-economic factors projected to support the growth of the global as well as regional markets. The report on Motorcycle Suspension System also presents the
Clinical Trials Market Survey Report 2021 Along with Statistics, Forecasts till …
The study offers a long-term forecast of the clinical trials landscape for the period between 2019 and 2029. The clinical trials landscape is projected to record a 4.5% CAGR through 2029. Collaboration at Its Peak: Key Strategy of Manufacturers in Clinical Trials Market For reducing economic burden, many companies are planning to shift their focus towards on-core business activities, thereby outsourcing their clinical trials activities to the CROs (contract research organizations). This
More Releases for Companion
A Smart Companion to your TV
Following HELLO’s very successful Kickstarter campaign (1339% funded), Solaborate is launching the new and improved HELLO 2 on Kickstarter, along with HELLO Touch TV, HELLO Creator Edition and 2 Gadget Extensions. A Smart Companion to your TV HELLO 2, like its predecessor, turns any TV into a video communication and collaboration device. HELLO 2 does everything users love about the original even better with Alexa support, home automation (Zigbee), and Android games,
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Farm & Companion Animal Health Market
Veterinary healthcare products include pharmaceuticals, nutrition (feed additives) and devices for both companion and livestock animals. Companion animals include pets such as dogs, cats and horses; although in recent years the market has expanded reasonably for avian pets, reptiles and exotic fish. The healthcare products have transformed the health and quality of life for millions of pets across the world. The greatest challenge of maintaining pets is seeking the keenness
Global Companion Diagnostics Market to Grow Globally
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Fashion accessories for mobile companion
Berlin / Llucmajor 13.07.2012. Protective covers for mobile phones, smartphones and tablets that are considered to have practical benefits and also to be fashion accessories, are the remit of the internationally active style for mobile GmbH in Berlin. The sold cases of the trademarks bugatti mobile cases and Jim Thomson not only meet the highest standards of quality, but also the requirements of the EU regarding environmental soundness of production